# Josep Carreras Leukaemia Research Institute

> research institute in Catalonia

**Wikidata**: [Q30287826](https://www.wikidata.org/wiki/Q30287826)  
**Wikipedia**: [English](https://en.wikipedia.org/wiki/Josep_Carreras_Leukaemia_Research_Institute)  
**Source**: https://4ort.xyz/entity/josep-carreras-leukaemia-research-institute

## Summary
The Josep Carreras Leukaemia Research Institute (IJC) is a specialized medical research center in Catalonia, Spain, dedicated to advancing the understanding and treatment of leukemia, lymphoma, and other hematological diseases. Founded in 2010, it is named after renowned Spanish tenor José Carreras and operates as part of the CERCA Institute network. The institute focuses on translational research to improve patient outcomes through scientific innovation.

## Key Facts
- **Founded**: 2010  
- **Location**: Badalona, Catalonia, Spain (coordinates: 41.4855° N, 2.2398° E)  
- **Named After**: José Carreras, a celebrated Spanish tenor and leukemia survivor.  
- **Research Focus**: Leukemia, lymphoma, hematopoietic system diseases, bone marrow disorders, and myeloid neoplasms.  
- **Director**: Ari Melnick (as of 2023).  
- **Affiliation**: Part of the CERCA Institute, a Catalan government-supported research network.  
- **Contact**: Website (carrerasresearch.org), phone (+34-935-57-28-00), and headquarters at Ctra de Can Ruti, Camí de les Escoles, s/n, 08916 Badalona.  

## FAQs
### Q: When was the Josep Carreras Leukaemia Research Institute established?  
A: The institute was founded in 2010 to address critical gaps in leukemia and hematological disease research.  

### Q: What diseases does the institute specialize in studying?  
A: It focuses on leukemia, lymphoma, bone marrow disorders, and other malignancies of the hematopoietic system.  

### Q: Why is the institute named after José Carreras?  
A: The institute honors José Carreras, a world-renowned tenor and leukemia survivor, who has advocated for blood cancer research since his diagnosis in the 1980s.  

## Why It Matters  
The Josep Carreras Leukaemia Research Institute plays a pivotal role in advancing global efforts to combat leukemia and related disorders through cutting-edge research. By integrating basic science, clinical trials, and patient care, the institute bridges laboratory discoveries with real-world applications, improving diagnostic tools and therapies. As part of the CERCA network, it collaborates with international partners to accelerate progress in hematology and oncology. Its work directly impacts patient survival rates and quality of life, addressing a critical medical need for more effective, targeted treatments.  

## Notable For  
- **Specialized Focus**: One of few institutes globally dedicated exclusively to hematological malignancies.  
- **CERCA Affiliation**: Benefits from Catalonia’s robust research ecosystem and government support.  
- **International Collaboration**: Partners with global networks to share data and drive innovation.  
- **Patient Advocacy**: Honors José Carreras’ legacy by prioritizing research with direct clinical relevance.  

## Body  
### Overview  
The Josep Carreras Leukaemia Research Institute (IJC) is a Catalan research center established in 2010 under the CERCA program, a initiative of the Catalan Government to promote scientific excellence. It operates as a nonprofit organization, integrating research, education, and clinical translation.  

### Founding and Structure  
- **Inception**: 2010.  
- **Headquarters**: Badalona, Spain, at Ctra de Can Ruti, Camí de les Escoles, s/n (postal code 08916).  
- **Network**: Part of the CERCA Institute, ensuring collaboration with other Catalan research centers.  

### Research Focus  
The institute prioritizes:  
- **Leukemia and Lymphoma**: Investigating genetic and molecular mechanisms driving these cancers.  
- **Hematopoietic System Diseases**: Studying disorders affecting blood and bone marrow.  
- **Myeloid Neoplasms**: Developing therapies for conditions like acute myeloid leukemia (AML).  

### Leadership  
- **Director**: Ari Melnick, a distinguished hematologist-oncologist affiliated with ORCID (0000-0003-4490-6093).  

### Contact Information  
- **Website**: http://www.carrerasresearch.org/ (available in Catalan, Spanish, and English).  
- **Phone**: +34-935-57-28-00.  
- **Social Media**: Twitter (@CarrerasIJC) and LinkedIn (josep-carreras-leukaemia-research-institute).  

### Legacy  
Named in honor of José Carreras, the institute reflects his commitment to raising awareness and funding for leukemia research following his own battle with the disease. This connection strengthens public engagement and philanthropic support for its mission.

## References

1. GRID Release 2017-05-22
2. [Source](https://cerca.cat/c/vhir/)
3. [Source](https://orcid.org/0000-0003-4490-6093)
4. [Source](https://www.carrerasresearch.org/ca/noticies/el-dr-ari-melnick-nou-director-de-linstitut-de-recerca-contra-la-leucemia-josep-carreras)
5. [Source](https://twitter.com/CarrerasIJC)